Affinity DataIC50: 2.00E+3nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
TargetIntegrin alpha-5/beta-1(Homo sapiens (Human))
Riken Discovery Research Institute
Curated by ChEMBL
Riken Discovery Research Institute
Curated by ChEMBL
Affinity DataIC50: 7.00E+3nMAssay Description:Inhibition of human HeLa cell adhesion to fibronectinMore data for this Ligand-Target Pair
TargetIntegrin alpha-5/beta-1(Homo sapiens (Human))
Riken Discovery Research Institute
Curated by ChEMBL
Riken Discovery Research Institute
Curated by ChEMBL
Affinity DataIC50: 8.00E+3nMAssay Description:Inhibition of human A431 cell adhesion to fibronectinMore data for this Ligand-Target Pair
TargetIntegrin alpha-5/beta-1(Homo sapiens (Human))
Riken Discovery Research Institute
Curated by ChEMBL
Riken Discovery Research Institute
Curated by ChEMBL
Affinity DataIC50: 1.60E+4nMAssay Description:Inhibition of human HT-1080 cell adhesion to fibronectinMore data for this Ligand-Target Pair
Affinity DataIC50: 2.60E+4nMAssay Description:Tested for antagonist activityt against NK-2 receptor in rabbit pulmonary artery by using Neurokinin A as agonistMore data for this Ligand-Target Pair
Affinity DataIC50: >6.00E+4nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >6.20E+4nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >9.90E+4nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Tested for antagonist activityt against NK-2 receptor in rabbit pulmonary artery by using Neurokinin A as agonistMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Tested for antagonist activityt against NK-2 receptor in rabbit pulmonary artery by using Neurokinin A as agonistMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Tested for antagonist activityt against NK-2 receptor in rabbit pulmonary artery by using Neurokinin A as agonistMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.32E+5nMAssay Description:Tested for antagonist activityt against NK-2 receptor in rabbit pulmonary artery by using Neurokinin A as agonistMore data for this Ligand-Target Pair
Affinity DataIC50: >1.33E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.67E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.67E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.67E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.67E+5nMAssay Description:Tested for antagonist activityt against NK-2 receptor in rabbit pulmonary artery by using Neurokinin A as agonistMore data for this Ligand-Target Pair
Affinity DataIC50: >1.67E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.67E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.67E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.67E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: >1.67E+5nMAssay Description:Tested for antagonist activityt against NK-2 receptor in rabbit pulmonary artery by using Neurokinin A as agonistMore data for this Ligand-Target Pair
Affinity DataIC50: >1.67E+5nMAssay Description:Drug concentration needed to produce a 50% reduction of bovine brain tubulin polymerization relative to the controlMore data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+5nMAssay Description:Compound was tested for inhibitory activity against heparanaseMore data for this Ligand-Target Pair